Post by BioDuro

Jing Zhang, Ph.D., Director of Science Engagement at BioDuro, presented at Discovery and Development Europe 2026 in Berlin today on how DMPK strategies must evolve when working beyond Rule of 5 chemical space. From the limitations of traditional ADME approaches for covalent inhibitors to the unique PK challenges of oral PROTACs, her session made the case for why chemistry and DMPK integration from day one is non-negotiable for progressing these targets. If Jing's session resonated or you want to keep the conversation going, our team is at 𝗕𝗼𝗼𝘁𝗵 𝟭 for the rest of the event. Stop by, or reach out to schedule time with Jing directly. #DrugDiscovery #MedicinalChemistry #DMPK #DrugDiscoveryEurope